CBPL

The stock has been placed in Additional Surveillance Measure (ASM) list STASM - I.

Chandra Bhagat Pharma Ltd.

BSE: 542934

SME

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

49.90-2.6 (-4.95%)

14 Aug, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

37.65

P/E (TTM)

12.36

P/B

1.14

P/S (TTM)

0.32

EV/EBITDA

12.82

CAPE (5Y)

26.37

ROE (TTM)

9.66

ROCE (TTM)

5.48

ROA (TTM)

3.11

Avg 3Y ROE

5.99

Earnings 3Y CAGR

49.88

Sales 3Y CAGR

-0.96

Sales 5Y CAGR

10.46

Debt/Equity

0.50

Consensus TP

Strong Buy %

Promoter Holding

73.02

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Chandra Bhagat Pharma Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is cheap and PE TTM is at a discount to industry median

PE TTM of 12.36 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -59.57%

What is P/E Ratio?

Median: 30.57

Value 12.36

-0.85775.12

Negative

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Chandra Bhagat Pharma Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Chandra Bhagat Pharma Ltd. Shareholding Pattern

Quarterly breakdown of Chandra Bhagat Pharma Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Sep 2020	Mar 2021	Sep 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Total Promoter	70.42	70.42	71.80	71.80	70.11	69.09	68.24	68.69	68.77	69.29	71.20	72.19	73.02
Indian Promoter	70.42	70.42	71.80	71.80	70.11	69.09	68.24	68.69	68.77	69.29	71.20	72.19	73.02
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	-	-	-	-	-	0.85	0.85	2.22	2.22	0.48	0.61	0.61	0.00
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.85	0.85	1.33	1.33	0.48	0.61	0.61	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.89	0.89	0.00	0.00	0.00	0.00
Non-Institution	29.58	29.58	28.20	28.20	29.89	30.06	30.91	29.09	29.01	30.23	28.19	27.20	26.98
Bodies Corporate	0.08	5.94	8.51	8.30	10.67	10.54	10.95	10.63	10.17	13.77	12.84	11.74	12.05
Others (incl. Retail) No. of shareholders	29.50 167	23.64 144	19.69 91	19.90 75	19.22 107	19.52 107	19.96 125	18.46 111	18.84 130	16.46 294	15.35 297	15.46 280	14.93 261

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Chandra Bhagat Pharma Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Prachi Pranav Bhagat Director	March-2026	Market Purchase (Acquisition) 3rd Mar 2026	4.52 %	₹ 39.89	62.00 k	₹ 24.73 lac
Prachi Pranav Bhagat Director	February-2025	Market Purchase (Acquisition) 24th Feb 2025	2.97 %	₹ 67.00	42.00 k	₹ 28.14 lac
Prachi Pranav Bhagat Director	December-2024	Market Purchase (Acquisition) 2nd Dec 2024	2.02 %	₹ 68.84	64.00 k	₹ 44.06 lac
Prachi Pranav Bhagat Director	November-2024	Market Purchase (Acquisition) 27th Nov 2024	1.89 %	₹ 69.00	10.00 k	₹ 6.90 lac
Prachi Pranav Bhagat Director	November-2024	Market Purchase (Acquisition) 27th Nov 2024	1.62 %	₹ 72.00	20.00 k	₹ 14.40 lac
HEMANT C BHAGAT Promoter & Director	August-2023	Market Purchase (Acquisition) 31st Aug 2023	35.06 %	₹ 115.30	27.00 k	₹ 31.13 lac
HEMANT C BHAGAT Promoter & Director	August-2023	Market Purchase (Acquisition) 8th Aug 2023	34.64 %	₹ 119.42	31.00 k	₹ 37.02 lac
HEMANT C BHAGAT Promoter & Director	April-2023	Market Sale (Disposal) 28th Apr 2023	34.96 %	₹ 102.45	24.00 k	₹ 24.59 lac
HEMANT C BHAGAT Promoter & Director	February-2023	Market Sale (Disposal) 26th Feb 2023	36.21 %	₹ 100.43	49.00 k	₹ 49.21 lac
HEMANT C BHAGAT Promoter & Director	December-2022	Market Sale (Disposal) 12th Dec 2022	36.41 %	₹ 96.50	15.00 k	₹ 14.47 lac

No corporate action data available.

Company Profile

Overview of Chandra Bhagat Pharma Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Chandra Bhagat Pharma Limited is an India-based pharmaceutical company. The Company is engaged in the business of marketing pharmaceutical critical care and health care products. The Company is focused on marketing pharmaceutical formulations and products in the domestic and international market thr...

Key personnel

Ms. Rajni Dawani

Compliance Officer, Company Secretary

Mr. Hemant Chandravadan BhagatD

Executive Chairman of the Board, Managing Director

Mrs. Prachi Pranav BhagatD

Chief Financial Officer, Executive Director

Mr. Pranav Hemant BhagatD

Whole Time Director

Mr. Ravindra Gajanan AwatiD

Non-Executive Independent Director

Ms. Abha Praveen DoshiD

Non-Executive Independent Director

Incorporated on

10 Mar 2003

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

14 Feb 2020

Free Float

11,48,000

Website

https://cbcpharma.com/

Phone no.

+919930004507

Address

323-F, BHAGAT BHUVAN, DR. AMBEDKAR ROAD, MATUNGA (EAST), , 400019, India

Frequently Asked Questions

What is the current share price of Chandra Bhagat Pharma Ltd.?

The current share price of Chandra Bhagat Pharma Ltd. is ₹ 49.90 as of 14 Aug 2026.

What is the market capitalisation of Chandra Bhagat Pharma Ltd.?

The market capitalisation of Chandra Bhagat Pharma Ltd. stands at ₹ 37.65 Cr.

What is the PE ratio of Chandra Bhagat Pharma Ltd.?

The Price-to-Earnings (PE) ratio of Chandra Bhagat Pharma Ltd. is 12.36 as of the latest trailing twelve months data.

What is the ROE and ROCE of Chandra Bhagat Pharma Ltd.?

Chandra Bhagat Pharma Ltd. has a Return on Equity (ROE) of 9.66% and a Return on Capital Employed (ROCE) of 5.48% as per the latest financial reports.

What is the 52-week high and low of Chandra Bhagat Pharma Ltd.?

The 52-week high of Chandra Bhagat Pharma Ltd. is - and the 52-week low is -.

What is the dividend yield of Chandra Bhagat Pharma Ltd.?

The dividend yield of Chandra Bhagat Pharma Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Chandra Bhagat Pharma Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 14.93% of Chandra Bhagat Pharma Ltd. shares.

What sector does Chandra Bhagat Pharma Ltd. belong to?

Chandra Bhagat Pharma Ltd. operates in the Healthcare sector.

What is the beta of Chandra Bhagat Pharma Ltd.?

The beta of Chandra Bhagat Pharma Ltd. is 0.06, indicating its price volatility relative to the broader market.

What is the RSI of Chandra Bhagat Pharma Ltd.?

The 14-day Relative Strength Index (RSI) of Chandra Bhagat Pharma Ltd. is 69.15, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

Chandra Bhagat Pharma Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Chandra Bhagat Pharma Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Company Profile

Frequently Asked Questions

Stock Analysis

Company Profile